Methods |
Women allocated to 2 groups. The method of allocation was not reported |
Participants |
100 women attending in a county hospital, Zhejiang, China. Women had regular menstrual periods and a single act of unprotected intercourse within 120 h of attending the clinic |
Interventions |
Mife 25 mg + MTX 5 mg vs Mife 25 mg, single dose, orally |
Outcomes |
Observed number of pregnancies, side effects and changes in menstrual pattern |
Notes |
Observed pregnancy/total number of women: Mife + MTX: 0/50; Mife: 1/50
-
Side effects:
Nausea and vomiting: Mife + MTX 6/50; Mife 5/50
-
Changes in menstrual pattern:
Delay: Mife + MTX 22/50; Mife 20/49
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Mentioned randomisation but description not adequate |
Allocation concealment (selection bias) |
Unclear risk |
Method of allocation concealment not mentioned |
Blinding (performance bias and detection bias) All outcomes |
Unclear risk |
Not mentioned |
Incomplete outcome data (attrition bias) All outcomes |
Unclear risk |
No mention of post‐randomisation exclusion and loss to follow‐up |
Selective reporting (reporting bias) |
Low risk |
Reported planned outcomes |
Other bias |
Low risk |
None detected |